Stable Isotope Labeled Compounds Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Stable Isotope Labeled Compounds Market is Segmented by Type (Deuterium, Carbon-13, Oxygen-18, and Other Stable Isotopes), Application (Research and Development, Clinical Diagnostics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Stable Isotope Labeled Compounds Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Stable Isotope Labeled Compounds Market Size

Stable Isotope Labeled Compounds Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 3.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Stable Isotope Labeled Compounds Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Stable Isotope Labeled Compounds Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Stable Isotope Labeled Compounds Market Analysis

The Stable Isotope Labeled Compounds Market is expected to register a CAGR of 3.3% during the forecast period.

The emergence of COVID-19 opened the doors for drastic R&D across the world. Companies were working hard to cope with the coronavirus and understand the effective way to manage the disease. The pandemic had a significant impact on the stable isotope-labeled compounds market as R&D was on the rise. For instance, in June 2020, Cambridge Isotobes Laboratory Inc. announced that the company was assisting the researchers at the Massachusetts Institute of Technology, Cambridge, to investigate the structure and dynamics of membrane proteins found in pathogenic viruses such as SARS-CoV 2 by supplying 3C6 glucose isotope which is used in E. coli-based protein expression to enrich SARS CoV 2 and also with 13C for the general requirement for NMR investigations of this type. As the use of stable isotopes labeled compounds increased for research during the pandemic, it is observed that the market was positively impacted. However, currently, the market is in its pre-pandemic phase and is expected to witness healthy growth in the coming years.

The major factor attributing to the growth of the market include the increase in the incidence of cancer and the growing investments in R&D programs by the biotechnology and pharmaceutical companies are boosting the market growth.

As per the data from the American Cancer Society report published in 2022, it is observed that there will be around 1.91 million new cancer cases in the United States during 2022. Among the cancer cases, cancers of the genital and digestive systems are expected to be the highest, with 395,600 and 343,040 new cases, respectively. The data published by PubMed in August 2021 stated that stable isotope tracing is an essential technology to study the molecular mechanisms by which nutraceuticals modulate and target cancer metabolism. Furthermore, the use of positionally labeled tracers as exogenous nutrients and the monitoring of their downstream metabolites labeling patterns enable the analysis of the specific metabolic pathway activity in cancer. Therefore, with the significance of stable isotopes in cancers, a high incidence of the disease is expected to propel market growth in the coming years.

Furthermore, there is growing research in the proteomics industry, which is augmenting the market growth. For instance, as per the data from the Journal of Proteomics and Bioinformatics data published in September 2022, rapid advancements in proteomics are enabling its high utilization in the treatment of infectious diseases across the world. Protein steady-state levels, protein turnover, and protein localization can all be determined using stable isotope labeling with mass spectrometry (MS)-based proteomic analysis. Hence, with the increasing research in proteomics research and the application of stable isotopes in the same, the market studied is expected to witness strong growth in the forecast period.

However, the high cost of the isotope compounds is the major drawback of the market.

Stable Isotope Labeled Compounds Industry Overview

The stable isotope labelled compounds market is moderately competitive and consists of several major players. Some of the international companies that are present in this market are PerkinElmer Inc., Merck KGaA, Cambridge Isotope Laboratories Inc., JSC Isotope, Medical Isotopes Inc., Omicron Biochemicals Inc., Trace Sciences International, Alsachim, and Taiyo Nippon Sanso Corporation.

Stable Isotope Labeled Compounds Market Leaders

  1. PerkinElmer Inc

  2. Merck KGaA

  3. Cambridge Isotope Laboratories, Inc.

  4. JSC Isotope.

  5. Medical Isotopes, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Stable Isotope Labeled Compounds Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Stable Isotope Labeled Compounds Market News

  • Oct 2022: ORNL announced its contribution to building new facilities to make isotopes used in medical treatments and many other fields. The US Stable Isotope Production and Research Center will enrich stable isotopes used for cancer treatments, heart disease treatments, and space exploration.
  • Sept 2022: Cambridge Isotope Laboratories Inc. (CIL) partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude Lipid Yeast Extract.

Stable Isotope Labeled Compounds Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Proteomics Research
    • 4.2.2 Rising Prevalence of Cancer
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Labour
    • 4.3.2 High Cost of Stable Isotope-Labeled Compounds
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Deuterium
    • 5.1.2 Carbon-13
    • 5.1.3 Oxygen-18
    • 5.1.4 Other Stable Isotopes
  • 5.2 By Application
    • 5.2.1 Research and Development
    • 5.2.2 Clinical Diagnostics
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 PerkinElmer Inc.
    • 6.1.2 Merck KGaA
    • 6.1.3 Cambridge Isotope Laboratories Inc.
    • 6.1.4 JSC Isotope
    • 6.1.5 Medical Isotopes Inc.
    • 6.1.6 Omicron Biochemicals Inc.
    • 6.1.7 Trace Sciences International
    • 6.1.8 Alsachim
    • 6.1.9 Taiyo Nippon Sanso Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Stable Isotope Labeled Compounds Industry Segmentation

As per the scope of the report, a stable isotope-labeled compound is a chemical substance in which part of the molecules are labeled with an isotope so that observations of the isotopic composition make it possible to follow the compound or its fragments through physical, chemical, or biological processes. 

The Stable Isotope Labeled Compounds Market is Segmented by Type (Deuterium, Carbon-13, Oxygen-18, and Other Stable Isotopes), Application (Research and Development, Clinical Diagnostics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above segments. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.

By Type Deuterium
Carbon-13
Oxygen-18
Other Stable Isotopes
By Application Research and Development
Clinical Diagnostics
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Stable Isotope Labeled Compounds Market Research FAQs

What is the current Stable Isotope Labeled Compounds Market size?

The Stable Isotope Labeled Compounds Market is projected to register a CAGR of 3.3% during the forecast period (2025-2030)

Who are the key players in Stable Isotope Labeled Compounds Market?

PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope. and Medical Isotopes, Inc. are the major companies operating in the Stable Isotope Labeled Compounds Market.

Which is the fastest growing region in Stable Isotope Labeled Compounds Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Stable Isotope Labeled Compounds Market?

In 2025, the North America accounts for the largest market share in Stable Isotope Labeled Compounds Market.

What years does this Stable Isotope Labeled Compounds Market cover?

The report covers the Stable Isotope Labeled Compounds Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Stable Isotope Labeled Compounds Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Isotope Labelled Compounds Industry Report

Statistics for the 2025 Stable Isotope Labeled Compounds market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Stable Isotope Labeled Compounds analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.